Awarded Grants
Awarded Grants
Using human retinal organoids to discover mechanisms and therapies for CRB1 retinopathy
Brian Ballios
University Health Network
$66,991
Awardee: Brian Ballios
Institution: University Health Network
Grant Amount: $66,991
Funding Period: February 1, 2025 - January 31, 2026
Summary:
Mutations in the CRB1 gene cause early cellular disorganization of the retina and loss of the light-sensitive photoreceptors in the eye, leading to irreversible blindness in children and adolescents. No treatments exist for these diseases. Structural differences between rodent and human retinal tissue preclude the use of animal models to uncover new therapies. Our work uses human CRB1 patient-derived stem cells to generate retinal “mini-organs in a dish” (organoids) to model CRB1 disease in the lab. Retinal organoids exhibit the same structure and major cell types found in the human retina; our CRB1 retinal organoids have the exact genetic makeup as the patient they were derived from. Comparisons of early retinal development in our CRB1 organoids with those derived from a healthy donor have shown defects in cell birth and proliferation. We aim to characterize how these early abnormalities affect the mature structure and organization of the retina in older organoids. We will analyse gene expression differences between healthy and CRB1-diseased organoids to uncover mechanisms and pathways involved in causing the disease state. These will serve as targets for testing new therapies for CRB1 disease using drugs known to modulate those pathways, and observe whether we can reverse early developmental defects.
Targeting retinoid traffic for treatment of CRB1-CRUMB1 degenerative retinal disorders
Konstantin Petrukhin
Columbia University Medical Center
$40,177
Awardee: Konstantin Petrukhin
Institution: Columbia University Medical Center
Grant Amount: $44,037
Characterisation of CRB1 patient human iPSC-derived retinal organoids to set-up potency assays for gene therapy
Jan Wijnholds
Leiden University Medical
$40,177
Awardee: Jan Wijnholds
Institution: Leiden University Medical
Award Amount: $40,177
AAV gene therapy on cultured human iPSC-derived retina with loss of CRB1 and CRB2
Jan Winjholds
Leiden University Medical Center (LUMC)
$50,312
Awardee: Jan Winjholds
Institution: Leiden University Medical Center (LUMC)
Award Amount: $50,312
Funding Period: February 1, 2019 - January 31, 2020
CRB1-null human retinal organoids for disease modeling and gene therapy testing
Wei Liu
Albert Einstein College of Medicine
$50,312
Awardee: Wei Liu
Institution: Albert Einstein College of Medicine
Award Amount: $50,312
Funding Period: February 1, 2019 - January 31, 2020
Functional dissection of CRB1 homophilic interactions in Retinitis pigmentosa
Toby Hurd
University of Edinburgh
$50,497
Awardee: Toby Hurd
Institution: University of Edinburgh
Award Amount: $50,497
Funding Period: January 1, 2018 - December 31, 2018
Establishing 3-Dimensional (3D) Retinal Optic Cups using patient-specific CRB1 Induced Pluripotent Stem Cells.
Jason Mills
University of Pennsylvania
50,500
Awardee: Jason Mills
Institution: University of Pennsylvania
Award Amount: $50,500
Funding Period: January 1, 2017 - December 31, 2017
Mutated CRB1 in human induced pluripotent stem cell derived retinal organoids
Stefan Liebau & Marius Ueffing
Eberhard Karls University Tuebingen, Institute of Neuroanatomy
$50,500
Awardee: Stefan Liebau & Marius Ueffing
Institution: Eberhard Karls University Tuebingen, Institute of Neuroanatomy
Award Amount: $50,500
Funding Period: January 1, 2017 - December 31, 2017